Evaluation of a ddPCR technology for the SARS-CoV-2 detection based on different types of samples in cancer patients with suspicion of COVID-19 (symptomatic) FRESH-PEF73849-en Ellen BLANC Evaluation of a ddPCR technology for the SARS-CoV-2 detection based on different types of samples in cancer patients with suspicion of COVID-19 (symptomatic) ONCOVID-21 FRESH-PEF73849-en 73849 FRESH-PEF73849 NCT04510454 Bénédicte MASTROIANNI CENTRE LEON BERARD Epidemiology France Portal (PEF) null SARSCOV2 CANCER ddPCR RT-qPCR SEROLOGICAL ASSAYS Oncology Infectious disease medicine Neoplasms COVID-19 To determine the ddPCR ability to detect the SARS-CoV-2 in nasopharyngeal samples of symptomatic patients with suspected COVID-19 infection using an IgG serological assay (EUROIMMUN Anti-SARS-Cov2 ELISA IgG) as gold/reference standard (FDA validated commercial serologic test). The primary endpoint will be the sensibility of the ddPCR assay for SARS-CoV-2 detection based on nasopharyngeal samples. null France Individuals Patients population 1. Age ≥ 18 years on the day of signing informed consent. 2. Confirmed diagnosis of any type of solid or hematologic tumor. 3. Ongoing anticancer treatment at the time of inclusion or within the last 3 months prior to inclusion (last treatment administration or last loco regional procedure) 4. Suspicion of COVID-19 infection. Patients must not have underwent diagnostic test and/or chest imaging before inclusion. * At least one of the following clinical symptoms: fever (>38°C), dry cough, fatigue, pulmonary involvement (febrile respiratory infection or respiratory difficulties), pharyngalgia, headaches, myalgia, gastrointestinal symptoms including abdominal pain and diarrhea, anosmia and agueusia, radiological signs of pneumonia as described by Shi et al. 5. Covered by a medical/health insurance. 6. Signed and dated informed consent form. Clinical data Biological data Other < 500 individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study Unknown To be defined